Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.20
+1.3%
$1.77
$0.88
▼
$2.34
$142.00M0.88833,917 shs1.28 million shs
SmartRent, Inc. stock logo
SMRT
SmartRent
$1.18
+2.2%
$1.27
$0.91
▼
$2.20
$225.14M1.641.32 million shs300,222 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-4.07%-10.61%-40.85%+2.61%+13.46%
SmartRent, Inc. stock logo
SMRT
SmartRent
-0.86%-4.15%0.00%+17.02%-17.20%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.20
+1.3%
$1.77
$0.88
▼
$2.34
$142.00M0.88833,917 shs1.28 million shs
SmartRent, Inc. stock logo
SMRT
SmartRent
$1.18
+2.2%
$1.27
$0.91
▼
$2.20
$225.14M1.641.32 million shs300,222 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-4.07%-10.61%-40.85%+2.61%+13.46%
SmartRent, Inc. stock logo
SMRT
SmartRent
-0.86%-4.15%0.00%+17.02%-17.20%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
2.50
Moderate Buy$10.00736.82% Upside
SmartRent, Inc. stock logo
SMRT
SmartRent
2.00
Hold$1.4825.53% Upside

Current Analyst Ratings Breakdown

Latest ITIM, CRDL, SMRT, and CLBS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/13/2026
SmartRent, Inc. stock logo
SMRT
SmartRent
Initiated CoverageBuy$1.75
10/2/2026
SmartRent, Inc. stock logo
SMRT
SmartRent
UpgradeSell (E+) ➝ Sell (D-)
9/23/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Reiterated RatingBuy$9.00
9/21/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Reiterated RatingSell (D-)
9/11/2026
SmartRent, Inc. stock logo
SMRT
SmartRent
DowngradeSell (D-) ➝ Sell (E+)
8/26/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Initiated CoverageBuy$11.00
8/25/2026
SmartRent, Inc. stock logo
SMRT
SmartRent
UpgradeSell (E+) ➝ Sell (D-)
8/17/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Boost Price TargetBuy$8.00 ➝ $10.00
8/6/2026
SmartRent, Inc. stock logo
SMRT
SmartRent
DowngradeSell (D-) ➝ Sell (E+)
7/21/2026
SmartRent, Inc. stock logo
SMRT
SmartRent
UpgradeSell (E+) ➝ Sell (D-)
7/14/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Reiterated RatingBuy
(Data available from 10/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/A$0.11 per shareN/A
SmartRent, Inc. stock logo
SMRT
SmartRent
$152.33M1.48N/AN/A$1.23 per share0.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$24.20M-$0.25N/AN/AN/AN/A-180.44%-140.28%11/12/2026 (Estimated)
SmartRent, Inc. stock logo
SMRT
SmartRent
-$60.56M-$0.10N/AN/AN/A-12.97%-8.50%-6.27%11/4/2026 (Estimated)

Latest ITIM, CRDL, SMRT, and CLBS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
SmartRent, Inc. stock logo
SMRT
SmartRent
-$0.02N/AN/AN/A$39.89 millionN/A
8/13/2026Q2 2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$0.09-$0.04+$0.05-$0.04N/AN/A
8/5/2026Q2 2026
SmartRent, Inc. stock logo
SMRT
SmartRent
-$0.02-$0.03-$0.01-$0.03$39.62 million$38.39 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/AN/A
SmartRent, Inc. stock logo
SMRT
SmartRent
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/A
5.55
5.55
SmartRent, Inc. stock logo
SMRT
SmartRent
N/A
3.80
3.30

Institutional Ownership

CompanyInstitutional Ownership
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
12.49%
SmartRent, Inc. stock logo
SMRT
SmartRent
59.42%

Insider Ownership

CompanyInsider Ownership
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
5.25%
SmartRent, Inc. stock logo
SMRT
SmartRent
2.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
18118.93 million112.69 millionNot Optionable
SmartRent, Inc. stock logo
SMRT
SmartRent
418191.61 million187.21 millionOptionable

Recent News About These Companies

SmartRent (NYSE:SMRT) Shares Down 0.4% - Time to Sell?
SmartRent (NYSE:SMRT) Director Buys 15,000 Shares of Stock
SmartRent (SMRT) Gets a Hold from KBW
SmartRent, Inc. (SMRT) Q2 2026 Earnings Call Transcript
SmartRent Reports Second Quarter 2026 Financial Results
SmartRent Launches Hardware-Free Virtual Intercom

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cardiol Therapeutics stock logo

Cardiol Therapeutics NASDAQ:CRDL

$1.20 +0.02 (+1.27%)
As of 01:06 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

SmartRent stock logo

SmartRent NYSE:SMRT

$1.18 +0.03 (+2.17%)
As of 01:08 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SmartRent, Inc., an enterprise software company, provides an integrated smart home operating system to residential property owners and operators, homebuilders, institutional home buyers, developers, and residents in the United States. The company's products and solutions include smart apartments and homes, access control for buildings, common areas, and rental units, asset protection and monitoring, parking management, self-guided tours, and community and resident Wi-Fi. It also offers professional services to customers, which include training, installation, and support services. The company was founded in 2017 and is headquartered in Scottsdale, Arizona.